| RS121918784 |
SCN1A;SCN1A-AS1
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121918785 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918786 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918788 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, SCN1A-related disorder |
| RS121918789 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Generalized epilepsy with febrile seizures plus |
| RS121918791 |
SCN1A
|
Health Risk |
Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918792 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121918793 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918795 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121918796 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS121918797 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS121918799 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS121918800 |
SCN1A
|
Health Risk |
Likely pathogenic |
SCN1A-related disorder, Early-infantile DEE |
| RS121918801 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121918802 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
West syndrome, Severe myoclonic epilepsy in infancy |
| RS121918803 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121918805 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121918806 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS121918807 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121918808 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe myoclonic epilepsy in infancy, Inborn genetic diseases |
| RS121918809 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121918811 |
SCN1A
|
Health Risk |
Likely pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121918812 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121918813 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 1 |
| RS121918816 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS121918817 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autism, Severe myoclonic epilepsy in infancy |
| RS121918843 |
FOLR1
|
Health Risk |
Pathogenic |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS121918844 |
RPE65
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis 2 |
| RS1219204735 |
ADAMTSL4
|
Health Risk |
Pathogenic |
— |
| RS1219206348 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1219221888 |
LDB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS1219237924 |
DNAJC6
|
Health Risk |
Likely pathogenic |
Juvenile onset Parkinson disease 19A, Juvenile onset Parkinson disease 19A |
| RS1219265131 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1219266312 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1219270797 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1219277452 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1219288687 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1219299972 |
PYGM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type V |
| RS1219304070 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1219321065 |
COL9A3
|
Health Risk |
Pathogenic |
— |
| RS1219334377 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1219344385 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1219390670 |
SLC26A2
|
Health Risk |
Pathogenic |
Achondrogenesis, type IB |
| RS1219402916 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1219417104 |
IDUA
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS1219418471 |
MAPKBP1
|
Health Risk |
Likely pathogenic |
MAPKBP1-related disorder, MAPKBP1-related disorder |
| RS1219432457 |
GYS1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS1219435870 |
BRIP1
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1219437391 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1219440385 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1219455303 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS1219458189 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS1219458778 |
CYBC1
|
Health Risk |
Likely pathogenic |
— |
| RS1219459429 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1219472164 |
MMAA
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblA type |
| RS1219480195 |
CSF3R
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Autosomal recessive severe congenital neutropenia due to CSF3R deficiency |
| RS1219483069 |
ARSB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1219484230 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS1219484408 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1DD |
| RS1219489337 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1219494274 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Infantile hypophosphatasia, Hypophosphatasia |
| RS1219497521 |
SPINK5
|
Health Risk |
Likely pathogenic |
Ichthyosis linearis circumflexa, Ichthyosis linearis circumflexa |
| RS1219505844 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1219516037 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS1219522144 |
ACE
|
Health Risk |
Pathogenic |
— |
| RS1219556604 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1219605974 |
MTRR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblE, Methylcobalamin deficiency type cblE |
| RS1219608074 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS1219632810 |
SLC19A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotin-responsive basal ganglia disease, Biotin-responsive basal ganglia disease |
| RS1219639490 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS121964845 |
TPI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS121964848 |
TPI1
|
Health Risk |
Pathogenic |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS121964849 |
TPI1
|
Health Risk |
Pathogenic |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS121964850 |
TPI1
|
Health Risk |
Pathogenic |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS121964852 |
TPM3
|
Health Risk |
Pathogenic |
Congenital myopathy 4B, autosomal recessive |
| RS121964853 |
TPM3
|
Health Risk |
Likely pathogenic |
Congenital myopathy with fiber type disproportion, Congenital myopathy 4A |
| RS1219648533 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome |
| RS121964854 |
TPM3
|
Health Risk |
Pathogenic |
Congenital myopathy with fiber type disproportion, Congenital myopathy 4B |
| RS121964855 |
TNNT2
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2 |
| RS121964856 |
TNNT2
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 2, Hypertrophic cardiomyopathy |
| RS121964858 |
TNNT2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 2, Dilated cardiomyopathy 1D |
| RS121964860 |
TNNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1D, Hypertrophic cardiomyopathy 2 |
| RS121964862 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS121964863 |
DDR2
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS121964864 |
DDR2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS121964865 |
DDR2
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome |
| RS121964866 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS121964868 |
NTRK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS121964869 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Charcot-Marie-Tooth disease |
| RS121964870 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS121964873 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast lobular carcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS121964874 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS121964875 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS121964876 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS121964877 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS121964878 |
CDH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS121964879 |
ATP6V1B1
|
Health Risk |
Pathogenic |
Renal tubular acidosis with progressive nerve deafness, Renal tubular acidosis with progressive nerve deafness |
| RS121964880 |
ATP6V1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Nephrolithiasis |
| RS121964881 |
ATP6V1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Renal tubular acidosis with progressive nerve deafness, Inborn genetic diseases |
| RS121964882 |
AVP
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurohypophyseal diabetes insipidus, Neurohypophyseal diabetes insipidus |